These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

416 related items for PubMed ID: 16540312

  • 1. Inhibition of the mammalian target of rapamycin (mTOR) by rapamycin increases chemosensitivity of CaSki cells to paclitaxel.
    Faried LS, Faried A, Kanuma T, Nakazato T, Tamura T, Kuwano H, Minegishi T.
    Eur J Cancer; 2006 May; 42(7):934-47. PubMed ID: 16540312
    [Abstract] [Full Text] [Related]

  • 2. Activation of mTOR signaling pathway contributes to survival of cervical cancer cells.
    Ji J, Zheng PS.
    Gynecol Oncol; 2010 Apr; 117(1):103-8. PubMed ID: 20102778
    [Abstract] [Full Text] [Related]

  • 3. Antiproliferative effects of rapamycin as a single agent and in combination with carboplatin and paclitaxel in head and neck cancer cell lines.
    Aissat N, Le Tourneau C, Ghoul A, Serova M, Bieche I, Lokiec F, Raymond E, Faivre S.
    Cancer Chemother Pharmacol; 2008 Jul; 62(2):305-13. PubMed ID: 17912526
    [Abstract] [Full Text] [Related]

  • 4. Differential sensitivity of paclitaxel-induced apoptosis in human esophageal squamous cell carcinoma cell lines.
    Faried A, Faried LS, Kimura H, Sohda M, Nakajima M, Miyazaki T, Kato H, Kanuma T, Kuwano H.
    Cancer Chemother Pharmacol; 2006 Feb; 57(3):301-8. PubMed ID: 16028102
    [Abstract] [Full Text] [Related]

  • 5. Expression of an activated mammalian target of rapamycin in adenocarcinoma of the cervix: A potential biomarker and molecular target therapy.
    Faried LS, Faried A, Kanuma T, Aoki H, Sano T, Nakazato T, Tamura T, Kuwano H, Minegishi T.
    Mol Carcinog; 2008 Jun; 47(6):446-57. PubMed ID: 18058806
    [Abstract] [Full Text] [Related]

  • 6. Rapamycin induces apoptosis of JN-DSRCT-1 cells by increasing the Bax : Bcl-xL ratio through concurrent mechanisms dependent and independent of its mTOR inhibitory activity.
    Tirado OM, Mateo-Lozano S, Notario V.
    Oncogene; 2005 May 05; 24(20):3348-57. PubMed ID: 15782132
    [Abstract] [Full Text] [Related]

  • 7. Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer.
    Liu H, Zang C, Emde A, Planas-Silva MD, Rosche M, Kühnl A, Schulz CO, Elstner E, Possinger K, Eucker J.
    Eur J Pharmacol; 2008 Sep 04; 591(1-3):43-51. PubMed ID: 18588872
    [Abstract] [Full Text] [Related]

  • 8. Targeting mammalian target of rapamycin synergistically enhances chemotherapy-induced cytotoxicity in breast cancer cells.
    Mondesire WH, Jian W, Zhang H, Ensor J, Hung MC, Mills GB, Meric-Bernstam F.
    Clin Cancer Res; 2004 Oct 15; 10(20):7031-42. PubMed ID: 15501983
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of Hsp90 inhibition for induction of apoptosis and inhibition of growth in cervical carcinoma cells in vitro and in vivo.
    Schwock J, Pham NA, Cao MP, Hedley DW.
    Cancer Chemother Pharmacol; 2008 Apr 15; 61(4):669-81. PubMed ID: 17579866
    [Abstract] [Full Text] [Related]

  • 10. Involvement of both extrinsic and intrinsic apoptotic pathways in apoptosis induced by genistein in human cervical cancer cells.
    Kim SH, Kim SH, Lee SC, Song YS.
    Ann N Y Acad Sci; 2009 Aug 15; 1171():196-201. PubMed ID: 19723056
    [Abstract] [Full Text] [Related]

  • 11. [The mTOR inhibitor enhances chemosensitivity of androgen-independent prostate cancer cell line].
    Xia JS, Chen XG, Zhuang QY, Liu JH, Ye ZQ.
    Zhonghua Nan Ke Xue; 2009 Jul 15; 15(7):617-20. PubMed ID: 19694375
    [Abstract] [Full Text] [Related]

  • 12. Sensitivity to Fas-mediated apoptosis in high-risk HPV-positive human cervical cancer cells: relationship with Fas, caspase-8, and Bid.
    Hougardy BM, van der Zee AG, van den Heuvel FA, Timmer T, de Vries EG, de Jong S.
    Gynecol Oncol; 2005 May 15; 97(2):353-64. PubMed ID: 15863130
    [Abstract] [Full Text] [Related]

  • 13. AICAR inhibits proliferation and induced S-phase arrest, and promotes apoptosis in CaSki cells.
    Guan TJ, Qin FJ, Du JH, Geng L, Zhang YY, Li M.
    Acta Pharmacol Sin; 2007 Dec 15; 28(12):1984-90. PubMed ID: 18031613
    [Abstract] [Full Text] [Related]

  • 14. Rapamycin causes poorly reversible inhibition of mTOR and induces p53-independent apoptosis in human rhabdomyosarcoma cells.
    Hosoi H, Dilling MB, Shikata T, Liu LN, Shu L, Ashmun RA, Germain GS, Abraham RT, Houghton PJ.
    Cancer Res; 1999 Feb 15; 59(4):886-94. PubMed ID: 10029080
    [Abstract] [Full Text] [Related]

  • 15. The mTOR inhibitor RAD001 sensitizes tumor cells to the cytotoxic effect of carboplatin in breast cancer in vitro.
    Liu H, Zang C, Schefe JH, Schwarzlose-Schwarck S, Regierer AC, Elstner E, Schulz CO, Scholz C, Possinger K, Eucker J.
    Anticancer Res; 2011 Sep 15; 31(9):2713-22. PubMed ID: 21868512
    [Abstract] [Full Text] [Related]

  • 16. Synergistic effect of rapamycin and cisplatin in endometrial cancer cells.
    Bae-Jump VL, Zhou C, Boggess JF, Gehrig PA.
    Cancer; 2009 Sep 01; 115(17):3887-96. PubMed ID: 19484784
    [Abstract] [Full Text] [Related]

  • 17. 3,3'-diindolylmethane and paclitaxel act synergistically to promote apoptosis in HER2/Neu human breast cancer cells.
    McGuire KP, Ngoubilly N, Neavyn M, Lanza-Jacoby S.
    J Surg Res; 2006 May 15; 132(2):208-13. PubMed ID: 16580691
    [Abstract] [Full Text] [Related]

  • 18. Mammalian target of rapamycin inhibitors rapamycin and RAD001 (everolimus) induce anti-proliferative effects in GH-secreting pituitary tumor cells in vitro.
    Gorshtein A, Rubinfeld H, Kendler E, Theodoropoulou M, Cerovac V, Stalla GK, Cohen ZR, Hadani M, Shimon I.
    Endocr Relat Cancer; 2009 Sep 15; 16(3):1017-27. PubMed ID: 19509067
    [Abstract] [Full Text] [Related]

  • 19. Damaged microtubules can inactivate BCL-2 by means of the mTOR kinase.
    Calastretti A, Bevilacqua A, Ceriani C, Viganò S, Zancai P, Capaccioli S, Nicolin A.
    Oncogene; 2001 Sep 27; 20(43):6172-80. PubMed ID: 11593425
    [Abstract] [Full Text] [Related]

  • 20. Enhanced radiation damage of tumor vasculature by mTOR inhibitors.
    Shinohara ET, Cao C, Niermann K, Mu Y, Zeng F, Hallahan DE, Lu B.
    Oncogene; 2005 Aug 18; 24(35):5414-22. PubMed ID: 15940265
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.